BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 888100)

  • 1. Hepatorenal syndrome: reversal by peritoneovenous shunt.
    Fullen WD
    Surgery; 1977 Sep; 82(3):337-41. PubMed ID: 888100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal failure in ascites secondary to hepatic, renal, and pancreatic disease. Treatment with a LeVeen peritoneovenous shunt.
    Wapnick S; Grosberg S; Kinney M; Azzara V; LeVeen HH
    Arch Surg; 1978 May; 113(5):581-5. PubMed ID: 646616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatorenal syndrome. Recovery after peritoneovenous shunt.
    Pladson TR; Parrish RM
    Arch Intern Med; 1977 Sep; 137(9):1248-9. PubMed ID: 901096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneovenous shunting for ascites.
    Reinhardt GF; Stanley MM
    Surg Gynecol Obstet; 1977 Sep; 145(3):419-24. PubMed ID: 888064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatorenal syndrome. Reversal with LeVeen shunt.
    Grosberg SJ; Wapnick S; Leveen H; Reddy AN
    N Y State J Med; 1978 Mar; 78(4):637-9. PubMed ID: 273754
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of hepatorenal syndrome.
    Schwartz ML; Vogel SB
    Am J Surg; 1980 Mar; 139(3):370-3. PubMed ID: 7362005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneovenous (LeVeen) shunt. Control of renin-aldosterone system in cirrhotic ascites.
    Witte MH; Witte CL; Jacobs S; Kut R
    JAMA; 1978 Jan; 239(1):31-3. PubMed ID: 579228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
    Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
    N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [12-year experience with continuous peritoneovenous shunt in the treatment of therapy-resistant ascites and hepatorenal failure: benefits and pitfalls].
    Kreuzer W
    Wien Klin Wochenschr; 1989 Jan; 101(2):87-91. PubMed ID: 2916345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 'hepatorenal' syndrome and refractory ascites. Successful therapy with the LeVeen-type peritoneal-venous shunt and valve.
    Kinney MJ; Schneider A; Wapnick S; Grosberg S; LeVeen H
    Nephron; 1979; 23(5):228-32. PubMed ID: 481657
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatic hydrothorax without diaphragmatic defect. An original surgical treatment.
    Montanari M; Orsi P; Pugliano G
    J Cardiovasc Surg (Torino); 1996 Aug; 37(4):425-7. PubMed ID: 8698792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hepatorenal syndrome: recovery after portacaval shunt.
    Ariyan S; Sweeney T; Kerstein MD
    Ann Surg; 1975 Jun; 181(6):847-9. PubMed ID: 1094971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of hemorrhagic syndrome caused by peritoneovenous shunt with a flow regulation device].
    Violi V; Montanari M; Roncoroni L
    G Chir; 1990; 11(7-8):413-5. PubMed ID: 2282274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The renal and hemodynamic effects of the peritoneovenous shunt for intractable hepatic ascites.
    Blendis LM; Greig PD; Langer B; Baigrie RS; Ruse J; Taylor BR
    Gastroenterology; 1979 Aug; 77(2):250-7. PubMed ID: 447039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites.
    Ginès A; Escorsell A; Ginès P; Saló J; Jiménez W; Inglada L; Navasa M; Clària J; Rimola A; Arroyo V
    Gastroenterology; 1993 Jul; 105(1):229-36. PubMed ID: 8514039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
    Arroyo V; Ginès P; Planas R
    Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneovenous shunting of intractable ascites in patients with cirrhosis: improving results and predictive factors of failure.
    Hillaire S; Labianca M; Borgonovo G; Smadja C; Grange D; Franco D
    Surgery; 1993 Apr; 113(4):373-9. PubMed ID: 8456392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of ascites in patients with end-stage liver disease.
    Saadeh S; Davis GL
    Rev Gastroenterol Disord; 2004; 4(4):175-85. PubMed ID: 15580152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ascites--a sign of death?].
    Nordin A; Mäkisalo H
    Duodecim; 2000; 116(19):2074-83; quiz 2084, 2165. PubMed ID: 12017728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.